Preferred Label : 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid;
MeSH note : has anti-atherosclerotic activity;
MeSH synonym : bempedoic acid;
MeSH hyponym : ESP-55016;
Is substance : O;
UNII : 1EJ6Z6Q368;
Origin ID : C581236;
UMLS CUI : C3659310;
- ATC code(s)
- Currated CISMeF NLP mapping
- MeSH indexing information
- MeSH term(s) associated for indexing
- Pharmacological action(s)
- Record concept(s)
- See also inter- (CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
https://www.ema.europa.eu/en/medicines/human/EPAR/nustendi
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug approval
europe
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
Ezetimibe
Ezetimibe
anticholesteremic agents
anticholesteremic agents
ATP citrate (pro-S)-Lyase
hypercholesterolemia
Primary hypercholesterolaemia
dyslipidemias
mixed dyslipidemia
adult
aged
administration, oral
bempedoic acid and ezetimibe
NPC1-Like Intracellular Cholesterol Transporter 1
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
dicarboxylic acids
fatty acids
dicarboxylic acids
fatty acids
---
https://www.ema.europa.eu/en/medicines/human/EPAR/nilemdo
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
bempedoic acid
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
drug approval
europe
anticholesteremic agents
anticholesteremic agents
drug therapy, combination
hydroxymethylglutaryl-coa reductase inhibitors
Primary hypercholesterolaemia
hypercholesterolemia
mixed dyslipidemia
dyslipidemias
administration, oral
ATP citrate (pro-S)-Lyase
product surveillance, postmarketing
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
dicarboxylic acids
fatty acids
dicarboxylic acids
fatty acids
---